ACRO Medical
  • Clinical Solutions
  • Research Solutions
  • Bio & Medical Intelligence
  • About Us
  • Insights
ENG / KOR
Contact Us
Clinical Solutions
  • Site Feasibility & Selection
  • PK / PD Modeling
  • Protocol Development
  • IND Strategy & Submission
  • Site Monitoring
  • Biostatistics
  • Data Use & Regulatory Strategy
Research Solutions
  • Publication Support
  • Medical Evidence Generation
Bio & Medical Intelligence
  • Data-driven Value Analysis
  • R&D Planning & Strategy
About Us
Insights
  • Insights →
ACRO Medical
  • Clinical Solutions
    • Site Feasibility & Selection
    • PK / PD Modeling
    • Protocol Development
    • IND Strategy & Submission
    • Site Monitoring
    • Biostatistics
    • Data Use & Regulatory Strategy
  • Research Solutions
    • Publication Support
    • Medical Evidence Generation
  • Bio & Medical Intelligence
    • Data-driven Value Analysis
    • R&D Planning & Strategy
  • About Us
  • Insights
ENG / KOR
Contact Us
Language Preference

Your browser language looks different from this page. 브라우저 언어와 현재 페이지 언어가 다릅니다.

Choose the language you would like to keep using on ACRO Medical.

ACRO Medical에서 계속 사용할 언어를 선택해 주세요.

Home / Insights
Insights

Articles, blog notes, and policy updates.

Methodological essays, regulatory commentary, and policy briefs from our biostatisticians, investigators, and health economists.

All Case Studies Articles Blog Policy Updates
ArticleJul 3, 2026

ESMO GI 2026 Merit Awards Recognize 20 Abstract Presenters

ESMO GI 2026 Merit Awards Recognize 20 Abstract Presenters

Read →
Case StudyJul 1, 2026

Feasibility done right: a Korean oncology case

PolicyJul 1, 2026

MFDS guidance update on RWE submissions

Case studies

Case StudyJul 1, 2026

Feasibility done right: a Korean oncology case

Latest articles

ArticleJul 3, 2026

ESMO GI 2026 Merit Awards Recognize 20 Abstract Presenters

ArticleJul 1, 2026

Adaptive design lessons from a Korean Phase II oncology trial

From the blog

BlogJul 1, 2026

What a single 'estimands' question changed about our SAP

Policy updates

PolicyJul 1, 2026

MFDS guidance update on RWE submissions

ACRO Medical

Academic Contract Research Organization. Anchored at a research-intensive university hospital — biostatistics, quantitative pharmacology, and oncology Phase 1 advisory.

Clinical Solutions
  • Site Feasibility & Selection
  • PK / PD Modeling
  • Protocol Development
  • IND Strategy & Submission
  • Site Monitoring
  • Biostatistics
  • Data Use & Regulatory Strategy
Research Solutions
  • Publication Support
  • Medical Evidence Generation
Bio & Medical Intelligence
  • Data-driven Value Analysis
  • R&D Planning & Strategy
About Us
Insights
© 2026 ACRO Medical. All rights reserved.